DuyKhanh Pham

1.5k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

DuyKhanh Pham is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, DuyKhanh Pham has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in DuyKhanh Pham's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (3 papers). DuyKhanh Pham is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (3 papers). DuyKhanh Pham collaborates with scholars based in United States and United Kingdom. DuyKhanh Pham's co-authors include Mark G. Kris, William Pao, Ennapadam Venkatraman, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely, Maureen F. Zakowski, Naiyer A. Rizvi, Allan R. Li and Steven I. Hanish and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

DuyKhanh Pham

9 papers receiving 1.2k citations

Hit Papers

Clinical Course of Patients with Non–Small Cell Lung Canc... 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
    2006 623 citations Gregory J. Riely, William Pao et al. Clinical Cancer Research profile →

Peers

DuyKhanh Pham
Anita Midha United Kingdom
Pierpaolo Camplese Italy
Sehhoon Park South Korea
Zoe Wainer Australia
Pil Gyu Hwang South Korea
Tejas Patil United States
Sigurd M. Hald Norway
Masaki Tokumo Japan
Miguel Tarón Spain
Reiko Kaji Japan
Anita Midha United Kingdom
DuyKhanh Pham
Citations per year, relative to DuyKhanh Pham DuyKhanh Pham (= 1×) peers Anita Midha

Countries citing papers authored by DuyKhanh Pham

Since Specialization
Citations

This map shows the geographic impact of DuyKhanh Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DuyKhanh Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DuyKhanh Pham more than expected).

Fields of papers citing papers by DuyKhanh Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DuyKhanh Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DuyKhanh Pham. The network helps show where DuyKhanh Pham may publish in the future.

Co-authorship network of co-authors of DuyKhanh Pham

This figure shows the co-authorship network connecting the top 25 collaborators of DuyKhanh Pham. A scholar is included among the top collaborators of DuyKhanh Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DuyKhanh Pham. DuyKhanh Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Weiss, Jared, John M. Kaczmar, Kevin J. Harrington, et al.. (2025). Versatile-002: Overall survival of HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab.. Journal of Clinical Oncology. 43(16_suppl). 6037–6037.
2.
Broderick, Stephen, Benjamin J. Golas, DuyKhanh Pham, et al.. (2010). SCCRO Promotes Glioma Formation and Malignant Progression in Mice. Neoplasia. 12(6). 476–484. 32 indexed citations
3.
Petersen, Rebecca P., DuyKhanh Pham, William R. Burfeind, et al.. (2007). Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer. The Annals of Thoracic Surgery. 83(4). 1245–1250. 214 indexed citations
4.
Marks, Jenifer L., Michael D. McLellan, Maureen F. Zakowski, et al.. (2007). Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4. PLoS ONE. 2(5). e426–e426. 74 indexed citations
5.
Sarkaria, Inderpal S., Maureen F. Zakowski, DuyKhanh Pham, et al.. (2007). Epidermal Growth Factor Receptor Signaling in Adenocarcinomas With Bronchioloalveolar Components. The Annals of Thoracic Surgery. 85(1). 216–223. 6 indexed citations
6.
Petersen, Rebecca P., DuyKhanh Pham, Eric M. Toloza, et al.. (2006). Thoracoscopic Lobectomy: A Safe and Effective Strategy for Patients Receiving Induction Therapy for Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 82(1). 214–219. 67 indexed citations
7.
Pham, DuyKhanh, Mark G. Kris, Gregory J. Riely, et al.. (2006). Use of Cigarette-Smoking History to Estimate the Likelihood of Mutations in Epidermal Growth Factor Receptor Gene Exons 19 and 21 in Lung Adenocarcinomas. Journal of Clinical Oncology. 24(11). 1700–1704. 177 indexed citations
8.
Riely, Gregory J., William Pao, DuyKhanh Pham, et al.. (2006). Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib. Clinical Cancer Research. 12(3). 839–844. 623 indexed citations breakdown →
9.
Pham, DuyKhanh, Mark G. Kris, Tiffani L. McDonough, et al.. (2005). Estimation of the likelihood of epidermal growth factor receptor (EGFR) mutations based on cigarette smoking history in patients with adenocarcinoma of the lung. Journal of Clinical Oncology. 23(16_suppl). 7069–7069. 4 indexed citations
10.
Sarkaria, Inderpal S., DuyKhanh Pham, Ronald Ghossein, et al.. (2004). SCCRO Expression Correlates With Invasive Progression in Bronchioloalveolar Carcinoma. The Annals of Thoracic Surgery. 78(5). 1734–1741. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita Midha Breakdown of academic impact, for papers by Pierpaolo Camplese Breakdown of academic impact, for papers by Sehhoon Park Breakdown of academic impact, for papers by Zoe Wainer Breakdown of academic impact, for papers by Pil Gyu Hwang Breakdown of academic impact, for papers by Tejas Patil Breakdown of academic impact, for papers by Sigurd M. Hald Breakdown of academic impact, for papers by Masaki Tokumo Breakdown of academic impact, for papers by Miguel Tarón Breakdown of academic impact, for papers by Reiko Kaji
Rankless by CCL
2026